Flemming Ørnskov

Flemming Ørnskov, M.D., MPH joined Galderma SA as Chief Executive Officer in October 2019.

Prior to joining Galderma, Flemming served as CEO of Shire plc from 2013 to 2019. Earlier in his career he held a number of leadership positions at Bayer, Novartis and Merck. He is currently a non-Executive Chairman of Waters Corporation and a board member of Karo Pharma AB.

Flemming qualified as a Doctor of Medicine at the University of Copenhagen Medical School and earned a Master of Public Health (MPH) from Harvard University School of Public Health and an MBA from INSEAD.